These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20203170)

  • 1. Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models.
    Lattanzi A; Neri M; Maderna C; di Girolamo I; Martino S; Orlacchio A; Amendola M; Naldini L; Gritti A
    Hum Mol Genet; 2010 Jun; 19(11):2208-27. PubMed ID: 20203170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy.
    Meneghini V; Lattanzi A; Tiradani L; Bravo G; Morena F; Sanvito F; Calabria A; Bringas J; Fisher-Perkins JM; Dufour JP; Baker KC; Doglioni C; Montini E; Bunnell BA; Bankiewicz K; Martino S; Naldini L; Gritti A
    EMBO Mol Med; 2016 May; 8(5):489-510. PubMed ID: 27025653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
    Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
    Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy.
    Lattanzi A; Salvagno C; Maderna C; Benedicenti F; Morena F; Kulik W; Naldini L; Montini E; Martino S; Gritti A
    Hum Mol Genet; 2014 Jun; 23(12):3250-68. PubMed ID: 24463623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
    Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
    Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy.
    Neri M; Ricca A; di Girolamo I; Alcala'-Franco B; Cavazzin C; Orlacchio A; Martino S; Naldini L; Gritti A
    Stem Cells; 2011 Oct; 29(10):1559-71. PubMed ID: 21809420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features.
    Rafi MA; Rao HZ; Luzi P; Luddi A; Curtis MT; Wenger DA
    Mol Genet Metab; 2015 Mar; 114(3):459-66. PubMed ID: 25533112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain.
    Dolcetta D; Perani L; Givogri MI; Galbiati F; Amadio S; Del Carro U; Finocchiaro G; Fanzani A; Marchesini S; Naldini L; Roncarolo MG; Bongarzone E
    J Gene Med; 2006 Aug; 8(8):962-71. PubMed ID: 16732552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates.
    Rosenberg JB; Sondhi D; Rubin DG; Monette S; Chen A; Cram S; De BP; Kaminsky SM; Sevin C; Aubourg P; Crystal RG
    Hum Gene Ther Clin Dev; 2014 Sep; 25(3):164-77. PubMed ID: 25144894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
    Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
    Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy.
    Sevin C; Benraiss A; Van Dam D; Bonnin D; Nagels G; Verot L; Laurendeau I; Vidaud M; Gieselmann V; Vanier M; De Deyn PP; Aubourg P; Cartier N
    Hum Mol Genet; 2006 Jan; 15(1):53-64. PubMed ID: 16311251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer.
    Sevin C; Verot L; Benraiss A; Van Dam D; Bonnin D; Nagels G; Fouquet F; Gieselmann V; Vanier MT; De Deyn PP; Aubourg P; Cartier N
    Gene Ther; 2007 Mar; 14(5):405-14. PubMed ID: 17093507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.
    Piguet F; Sondhi D; Piraud M; Fouquet F; Hackett NR; Ahouansou O; Vanier MT; Bieche I; Aubourg P; Crystal RG; Cartier N; Sevin C
    Hum Gene Ther; 2012 Aug; 23(8):903-14. PubMed ID: 22642214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axons mediate the distribution of arylsulfatase A within the mouse hippocampus upon gene delivery.
    Luca T; Givogri MI; Perani L; Galbiati F; Follenzi A; Naldini L; Bongarzone ER
    Mol Ther; 2005 Oct; 12(4):669-79. PubMed ID: 16087406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
    Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
    Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice.
    Rafi MA; Rao HZ; Luzi P; Wenger DA
    Mol Ther; 2015 Nov; 23(11):1681-1690. PubMed ID: 26329589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation.
    Pellegatta S; Tunici P; Poliani PL; Dolcetta D; Cajola L; Colombelli C; Ciusani E; Di Donato S; Finocchiaro G
    Neurobiol Dis; 2006 Feb; 21(2):314-23. PubMed ID: 16199167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy.
    Ricca A; Rufo N; Ungari S; Morena F; Martino S; Kulik W; Alberizzi V; Bolino A; Bianchi F; Del Carro U; Biffi A; Gritti A
    Hum Mol Genet; 2015 Jun; 24(12):3372-89. PubMed ID: 25749991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical aspects of globoid and metachromatic leukodystrophies.
    Farooqui AA; Horrocks LA
    Neurochem Pathol; 1984; 2(3):189-218. PubMed ID: 6152665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice.
    Consiglio A; Quattrini A; Martino S; Bensadoun JC; Dolcetta D; Trojani A; Benaglia G; Marchesini S; Cestari V; Oliverio A; Bordignon C; Naldini L
    Nat Med; 2001 Mar; 7(3):310-6. PubMed ID: 11231629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.